324 related articles for article (PubMed ID: 31930459)
1. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
[TBL] [Abstract][Full Text] [Related]
2. Timed Up and Go test, atrophy of medial temporal areas and cognitive functions in community-dwelling older adults with normal cognition and mild cognitive impairment.
Kose Y; Ikenaga M; Yamada Y; Morimura K; Takeda N; Ouma S; Tsuboi Y; Yamada T; Kimura M; Kiyonaga A; Higaki Y; Tanaka H;
Exp Gerontol; 2016 Dec; 85():81-87. PubMed ID: 27693131
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility.
Loggia G; Attoh-Mensah E; Pothier K; Morello R; Lescure P; Bocca ML; Marcelli C; Chavoix C
Front Pharmacol; 2019; 10():1659. PubMed ID: 32082159
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
Swami S; Cohen RA; Kairalla JA; Manini TM
Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
[TBL] [Abstract][Full Text] [Related]
6. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
7. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
8. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.
Cao YJ; Mager DE; Simonsick EM; Hilmer SN; Ling SM; Windham BG; Crentsil V; Yasar S; Fried LP; Abernethy DR
Clin Pharmacol Ther; 2008 Mar; 83(3):422-9. PubMed ID: 17713474
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
10. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.
Dos Santos ANM; Junior GAAG; Benseñor IM; Goulart AC; Brunoni AR; Viana MC; Lotufo PA; Suemoto CK
Eur J Clin Pharmacol; 2022 Sep; 78(9):1527-1534. PubMed ID: 35764818
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
[TBL] [Abstract][Full Text] [Related]
13. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
[TBL] [Abstract][Full Text] [Related]
14. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
[TBL] [Abstract][Full Text] [Related]
15. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
[TBL] [Abstract][Full Text] [Related]
17. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
[TBL] [Abstract][Full Text] [Related]
19. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
20. How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65 years and over?
Kusljic S; Woolley A; Lowe M; Manias E
Aging Clin Exp Res; 2020 Mar; 32(3):423-431. PubMed ID: 31124057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
